Study activity | Day | Month | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | -3-0 | 1 | 2 | 3 | 5 | 10 | 14/15 | 20/21 | 25/26 | 30 | 3 | 6 | 12 |
Patient baseline characteristics and transplant data | |||||||||||||
Informed consent | * | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Medical history | * | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Physical examin | * | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Graft history | * | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Pregnancy test | * | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Safety parameters | |||||||||||||
Vital signs | * | * | * | * | * | * | * | * | * | * | * | * | * |
Blood chemistry†| * | * | * | * | * | * | * | * | * | * | * | * | * |
Heamogram | * | * | * | * | * | * | * | * | * | * | * | * | * |
Coagulation lab†| * | * | * | * | * | * | * | * | * | * | * | * | * |
MPAtrough level | Â | * | * | * | * | * | * | * | * | * | * | * | * |
EVL trough level | Â | Â | Â | Â | Â | Â | * | * | * | * | * | * | * |
Ultrasound‡ |  | * | * | * |  | * |  |  |  |  |  |  |  |
Adverse events | Â | * | * | * | * | * | * | * | * | * | * | * | * |
Rejection¶ |  | * | * | * | * | * | * | * | * | * | * | * | * |
Efficacy parameters | |||||||||||||
eGFR | * | * | * | * | * | * | * | * | * | * | * | * | * |
Rejection|| | Â | * | * | * | * | * | * | * | * | * | * | * | * |